178 related articles for article (PubMed ID: 8891872)
1. Affinity of angiotensin I-converting enzyme (ACE) inhibitors for N- and C-binding sites of human ACE is different in heart, lung, arteries, and veins.
Bevilacqua M; Vago T; Rogolino A; Conci F; Santoli E; Norbiato G
J Cardiovasc Pharmacol; 1996 Oct; 28(4):494-9. PubMed ID: 8891872
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic data reveal the heterogeneity of angiotensin-converting enzyme according to its source (lung versus heart).
Vago T; Bevilacqua M; Conci F; Rogolino A; Norbiato G
Am J Cardiol; 1995 Jun; 75(18):13F-17F. PubMed ID: 7778528
[TBL] [Abstract][Full Text] [Related]
3. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
Perich RB; Jackson B; Rogerson F; Mendelsohn FA; Paxton D; Johnston CI
Mol Pharmacol; 1992 Aug; 42(2):286-93. PubMed ID: 1325031
[TBL] [Abstract][Full Text] [Related]
4. Variation in angiotensin-converting enzyme (ACE) inhibitor affinity at two binding sites on rat pulmonary ACE: influence on bradykinin hydrolysis.
Perich RB; Jackson B; Johnston CI
Clin Exp Pharmacol Physiol; 1992 May; 19(5):353-7. PubMed ID: 1325885
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues.
Vago T; Bevilacqua M; Conci F; Baldi G; Ongini E; Chebat E; Monopoli A; Norbiato G
Br J Pharmacol; 1992 Nov; 107(3):821-5. PubMed ID: 1335341
[TBL] [Abstract][Full Text] [Related]
6. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.
Wei L; Clauser E; Alhenc-Gelas F; Corvol P
J Biol Chem; 1992 Jul; 267(19):13398-405. PubMed ID: 1320019
[TBL] [Abstract][Full Text] [Related]
7. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.
Andújar-Sánchez M; Cámara-Artigas A; Jara-Pérez V
Biophys Chem; 2004 Oct; 111(2):183-9. PubMed ID: 15381315
[TBL] [Abstract][Full Text] [Related]
8. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.
Perich RB; Jackson B; Johnston CI
Eur J Pharmacol; 1994 Feb; 266(3):201-11. PubMed ID: 8174603
[TBL] [Abstract][Full Text] [Related]
9. Evidence for two binding sites on membrane-bound angiotensin-converting enzymes (ACE) for exogenous inhibitors except in testis.
Brée F; Hamon G; Tillement JP
Life Sci; 1992; 51(10):787-94. PubMed ID: 1325020
[TBL] [Abstract][Full Text] [Related]
10. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme.
Natesh R; Schwager SL; Evans HR; Sturrock ED; Acharya KR
Biochemistry; 2004 Jul; 43(27):8718-24. PubMed ID: 15236580
[TBL] [Abstract][Full Text] [Related]
11. The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380.
Corradi HR; Chitapi I; Sewell BT; Georgiadis D; Dive V; Sturrock ED; Acharya KR
Biochemistry; 2007 May; 46(18):5473-8. PubMed ID: 17439247
[TBL] [Abstract][Full Text] [Related]
12. Characterization of angiotensin I-converting enzyme (ACE)-containing follicles in the rat ovary during the estrous cycle and effects of ACE inhibitor on ovulation.
Daud AI; Bumpus FM; Husain A
Endocrinology; 1990 Jun; 126(6):2927-35. PubMed ID: 2161740
[TBL] [Abstract][Full Text] [Related]
13. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
Ehlers MR; Riordan JF
Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
[TBL] [Abstract][Full Text] [Related]
15. Localization of angiotensin converting enzyme in rat heart.
Yamada H; Fabris B; Allen AM; Jackson B; Johnston CI; Mendelsohn AO
Circ Res; 1991 Jan; 68(1):141-9. PubMed ID: 1845851
[TBL] [Abstract][Full Text] [Related]
16. Peptide inhibitors and the active site(s) of angiotensin converting enzyme.
Riordan JF; Chen YN; Kleemann SG; Bünning P
Biomed Biochim Acta; 1991; 50(4-6):809-14. PubMed ID: 1666286
[TBL] [Abstract][Full Text] [Related]
17. Characterization of angiotensin converting enzyme from rat tissue by radio-inhibitor binding studies.
Jackson B; Cubela R; Johnston CI
Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):681-9. PubMed ID: 3026703
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera.
Williams TA; Barnes K; Kenny AJ; Turner AJ; Hooper NM
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):875-81. PubMed ID: 1335236
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats.
Fabris B; Yamada H; Cubela R; Jackson B; Mendelsohn FA; Johnston CI
Br J Pharmacol; 1990 Jul; 100(3):651-5. PubMed ID: 2167741
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
